GlassScriptPhysician profile
Edward Paul Doherty
NPI 1417394131
$8,036.23
in general payments reported to CMS, 2019-2025
25 companies · $4,474 in 2025
The $4,474 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $740 · 2021: $44.02 · 2022: $11.91 · 2023: $269 · 2024: $1,768 · 2025: $4,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,038 · Travel and Lodging: $2,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,037.91 |
| Travel and Lodging | $2,473.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,846.69 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $1,082.04 | 2020-2025 | Proclaim, Eterna |
| Abbvie INC. | $1,079.08 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $659.83 | 2019-2025 | Relistor, Trulance |
| Valinor Pharma, LLC | $593.80 | 2024-2025 | Movantik |
| Collegium Pharmaceutical, INC. | $374.47 | 2019-2024 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $247.51 | 2025 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $148.07 | 2019-2025 | Ajovy |
| Pfizer INC. | $146.31 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $133.75 | 2019-2020 | |
| Allergan, INC. | $124.45 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $82.44 | 2019 | |
| Amgen INC. | $73.91 | 2019-2020 | |
| Daiichi Sankyo INC. | $67.29 | 2019 | |
| Biodelivery Sciences International, INC. | $58.10 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $49.63 | 2019 | |
| Saluda Medical Americas, INC. | $45.96 | 2025 | Evoke |
| Painteq LLC | $45.52 | 2024 | Painteq |
| Vertos Medical, INC. | $41.09 | 2020 | |
| Globus Medical, INC. | $34.99 | 2025 | Senza |
| Shionogi INC | $28.69 | 2019 | |
| Medtronic USA, INC. | $24.02 | 2019 | |
| Redhill Biopharma INC. | $23.85 | 2020 | |
| Kaleo, INC. | $12.83 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.